Agenzia Italiana del Farmaco
Direct communication with healthcare professionals on Voxzogo®️ (vosoritide) - Direct communication with healthcare professionals on Voxzogo®️ (vosoritide)
Direct communication with healthcare professionals on Voxzogo®️ (vosoritide)
Voxzogo® (vosoritide): change to administration syringe and needle leading to product administration in Units (U) instead of mL.
Summary
- From July 2023, Voxzogo co-packs will contain new solvent needles and new administration syringes due to supply chain reasons.
- The new solvent needle has an alternative safety mechanism with an activated safety shield cover (see Table 1).
- The new administration syringe has Units (U) graduation markings( typically used for insulin products and sometimes referred to as Insulin Units) instead of mL graduation markings (see Table 1).
- It is important that you explain to your patient or the caregiver the recommended dose to be delivered with the new syringe, as the units of measure are not 1:1. For example, 0.1 mL is equivalent to 10 U. Please see Table 2 for the conversion of single dose volumes from mL to U.
- There are no changes to the Voxzogo dosage or volume. Recommendations for use remain unchanged.
- The product information has been amended to reflect the use of new needles and syringes.
Published on: 04 September 2023
🔬 AIFA pubblica il dossier “Dalle terapie a taglia unica alle cure su misura: la rivoluzione della ...
Vai al post →
🎙️ “Immagino un futuro in cui ciascuno di noi abbia un vero e proprio passaporto farmacogenetico, m...
Vai al post →
💊 Quasi 4 cittadini su 10 hanno ricevuto almeno una prescrizione di #antibiotici nel 2024, con una ...
Vai al post →
⚠️ Attenzione alle false cure miracolose
Negli ultimi tempi si sta diffondendo un business pericol...
Vai al post →
#AIFA promuove l’ascolto e la trasparenza
Approvati i Regolamenti di “AIFA Ascolta” e “AIFA Incontr...
Vai al post →
Oggi si celebra il #WorldAutismAwarenessDay.
🔵 L'Agenzia Italiana del Farmaco sostiene la Giornata...
Vai al post →
